MicroRNA-20b Downregulates HIF-1α and Inhibits the Proliferation and Invasion of Osteosarcoma Cells

被引:36
作者
Liu, Ming [1 ]
Wang, Dan [1 ]
Li, Ning [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Orthopaed, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China
关键词
Osteosarcoma (OS); Hypoxia-inducible transcription factor-1 alpha (HIF-1 alpha); microRNA-20b (miR-20b); Vascular endothelial growth factor (VEGF) pathway; HYPOXIA; VEGF; ACTIVATION; PATHWAY; GROWTH; CANCER; STABILIZATION; TRANSCRIPTION; ANGIOGENESIS; METASTASIS;
D O I
10.3727/096504016X14562725373752
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Osteosarcoma (OS) is the most common malignant primary bone tumor disease. HIF-1 alpha was predicted to be the target gene of microRNA-20b (miR-20b). The present study was designed to illustrate the effect of miR-20b in regulating osteosarcoma via targeting HIF-1 alpha. In this study, we found that the expression of HIF-1 alpha was significantly increased, while miR-20b obviously decreased in OS patients and OS cell lines compared with healthy controls. Moreover, the luciferase report confirmed the targeting reaction between miR-20b and HIF-1 alpha. Additionally, the overexpression of miR-20b suppressed the invasion and growth of both MG63 and U2OS cells, and inhibited the expressions of HIF-1 alpha and VEGF pathway proteins, while the inhibition of miR-20b led to the reverse results. Furthermore, the overexpression of HIF-1 alpha affected the suppression effect of miR-20b in MG63 cells, indicating that miR-20b suppresses the tumor cell process via inhibiting the expression of HIF-1 alpha. Taken together, our results suggest that the upregulation of miR-20b affects the expression of HIF-1 alpha, downregulates the VEGF pathway proteins, and suppresses cell invasion and proliferation rate. These results provide a potential therapeutic strategy for osteosarcoma.
引用
收藏
页码:257 / 266
页数:10
相关论文
共 34 条
  • [1] MicroRNAs and other tiny endogenous RNAs in C-elegans
    Ambros, V
    Lee, RC
    Lavanway, A
    Williams, PT
    Jewell, D
    [J]. CURRENT BIOLOGY, 2003, 13 (10) : 807 - 818
  • [2] ARDI, 2014, CARDIOVASC DIABETOL, V13, P8
  • [3] miR-20b Modulates VEGF Expression by Targeting HIF-1α and STAT3 in MCF-7 Breast Cancer Cells
    Cascio, Sandra
    D'Andrea, Aleco
    Ferla, Rita
    Surmacz, Eva
    Gulotta, Eliana
    Amodeo, Valeria
    Bazan, Viviana
    Gebbi, Nicola
    Russo, Antonio
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2010, 224 (01) : 242 - 249
  • [4] GSK3β negatively regulates HIF1α mRNA stability via nucleolin in the MG63 osteosarcoma cell line
    Cheng, Dong-dong
    Zhao, Hai-guang
    Yang, Yun-song
    Hu, Tu
    Yang, Qing-cheng
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 443 (02) : 598 - 603
  • [5] Treatment of osteosarcoma at first recurrence after contemporary therapy - The Memorial Sloan-Kettering Cancer Center Experience
    Chou, AJ
    Merola, PR
    Wexler, LH
    Gorlick, RG
    Vyas, YM
    Healey, JH
    LaQuaglia, MP
    Huvos, AG
    Meyers, PA
    [J]. CANCER, 2005, 104 (10) : 2214 - 2221
  • [6] The Growth and Aggressive Behavior of Human Osteosarcoma Is Regulated by a CaMKII-Controlled Autocrine VEGF Signaling Mechanism
    Daft, Paul G.
    Yang, Yang
    Napierala, Dobrawa
    Zayzafoon, Majd
    [J]. PLOS ONE, 2015, 10 (04):
  • [7] Expression and stability of hypoxia inducible factor 1α in osteosarcoma
    El Naggar, Amal
    Clarkson, Paul
    Zhang, Fan
    Mathers, Joan
    Tognon, Cristina
    Sorensen, Poul H.
    [J]. PEDIATRIC BLOOD & CANCER, 2012, 59 (07) : 1215 - 1222
  • [8] Angiogenesis as a therapeutic target
    Ferrara, N
    Kerbel, RS
    [J]. NATURE, 2005, 438 (7070) : 967 - 974
  • [9] Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
  • [10] Giatromanolaki A, 2010, ANTICANCER RES, V30, P2831